Assessment of ARIA Sufficiency: Siliq (brodalumab)

    Basic Details
    Approval Date
    Wednesday, February 15, 2017
    Health Outcome(s)
    adverse pregnancy and fetal outcomes
    fatal major adverse cardiac events
    malignancy
    opportunistic infections
    outpatient neutropenia
    suicidal ideation and behavior